Searchable abstracts of presentations at key conferences in endocrinology

ea0077p60 | Metabolism, Obesity and Diabetes | SFEBES2021

Mimicking chronic hyperglycaemic conditions in primary human endothelial cell cultures using pathophysiological concentrations of glucose in prediabetes and type 2 diabetes

Luk Cheukyau , Haywood Natalie J , Kearney Mark T

Introduction: In the UK alone, diabetes affects nearly 4 million people and an additional 13.6 million people are estimated to be at high risk of developing type 2 diabetes (T2DM). Diabetes is associated with vascular complications which path the development of cardiovascular diseases such as strokes and heart attacks. Previous studies have shown various pathways in which hyperglycaemia leads to endothelial dysfunction and insulin resistance. However, current reports of <e...

ea0086p210 | Metabolism, Obesity and Diabetes | SFEBES2022

Elucidating endothelial-derived molecules with potential anti-obesity properties via crosstalk with enterocytes and gut microbiota

Luk Cheukyau , Haywood Natalie J , Cubbon Richard , Kearney Mark T

Introduction: Overweight and obesity is a worldwide chronic disease affecting 2 billion adults and millions of children. In diet-induced obesity (DIO), current treatments are not always effective or suitable for all patients due to the complexity of obesity and its associated health complications. Recently, the potential of developing weight loss therapy by targeting the gut microbiota has been raised. Previously, we have shown that mice overexpressing insulin-like growth fact...

ea0065p170 | Metabolism and Obesity | SFEBES2019

Chronic disruption of endothelial Insulin/IGF1 signaling pathway enhances whole body insulin sensitivity

Viswambharan Hema , Yuldasheva Nadira , Imrie Helen , Cubbon Richard , Bridge Katherine , Haywood Natalie , Skromna Anna , Porter Karen , Hemmings Karen , Clark Emily , Gatenby Victoria , Abudushalamu Yilizila , Cordell Paul , Simmons Katie , Makava Natallia , Walker Andrew , Futers Simon , Shah Ajay , Beech David , Wheatcroft Stephen , Kearney Mark , Sukumar Piruthivi

Type 2 diabetes is preceded by insulin resistance, followed by increased endothelial cell production of superoxide and reduction in bioavailability of the vasoprotective signalling molecule, nitric oxide (NO). We demonstrated in preclinical models that type 2 diabetes also causes resistance to insulin-like growth factor-1 (IGF-1) mediated glucose lowering and endothelial NO release. This study aimed to examine the effect of the endothelial cell-specific combination of insulin ...